BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 12852238)

  • 1. Management of transitional cell carcinoma.
    Henry CJ
    Vet Clin North Am Small Anim Pract; 2003 May; 33(3):597-613. PubMed ID: 12852238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of transitional cell carcinoma of the urinary bladder in dogs: a review.
    Fulkerson CM; Knapp DW
    Vet J; 2015 Aug; 205(2):217-25. PubMed ID: 25747698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder.
    Knapp DW; Richardson RC; Chan TC; Bottoms GD; Widmer WR; DeNicola DB; Teclaw R; Bonney PL; Kuczek T
    J Vet Intern Med; 1994; 8(4):273-8. PubMed ID: 7983623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development.
    Knapp DW; Ramos-Vara JA; Moore GE; Dhawan D; Bonney PL; Young KE
    ILAR J; 2014; 55(1):100-18. PubMed ID: 24936033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical signs, treatments, and outcome in cats with transitional cell carcinoma of the urinary bladder: 20 cases (1990-2004).
    Wilson HM; Chun R; Larson VS; Kurzman ID; Vail DM
    J Am Vet Med Assoc; 2007 Jul; 231(1):101-6. PubMed ID: 17605672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder.
    Greene SN; Lucroy MD; Greenberg CB; Bonney PL; Knapp DW
    J Am Vet Med Assoc; 2007 Oct; 231(7):1056-60. PubMed ID: 17916030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized phase III trial of piroxicam in combination with mitoxantrone or carboplatin for first-line treatment of urogenital tract transitional cell carcinoma in dogs.
    Allstadt SD; Rodriguez CO; Boostrom B; Rebhun RB; Skorupski KA
    J Vet Intern Med; 2015 Jan; 29(1):261-7. PubMed ID: 25619518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinoma.
    Schrempp DR; Childress MO; Stewart JC; Leach TN; Tan KM; Abbo AH; de Gortari AE; Bonney PL; Knapp DW
    J Am Vet Med Assoc; 2013 Jun; 242(11):1534-8. PubMed ID: 23683018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of carbon dioxide laser ablation combined with mitoxantrone and piroxicam treatment in dogs with transitional cell carcinoma.
    Upton ML; Tangner CH; Payton ME
    J Am Vet Med Assoc; 2006 Feb; 228(4):549-52. PubMed ID: 16478428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: a pilot study.
    Poirier VJ; Forrest LJ; Adams WM; Vail DM
    J Am Anim Hosp Assoc; 2004; 40(2):131-6. PubMed ID: 15007049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder.
    Arnold EJ; Childress MO; Fourez LM; Tan KM; Stewart JC; Bonney PL; Knapp DW
    J Vet Intern Med; 2011; 25(6):1385-90. PubMed ID: 22092632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects of deracoxib treatment in 26 dogs with transitional cell carcinoma of the urinary bladder.
    McMillan SK; Boria P; Moore GE; Widmer WR; Bonney PL; Knapp DW
    J Am Vet Med Assoc; 2011 Oct; 239(8):1084-9. PubMed ID: 21985349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of transitional cell carcinoma of the urinary bladder in dogs: important challenges to consider.
    Nolan MW; Gieger TL; Vaden SL
    Vet J; 2015 Aug; 205(2):126-7. PubMed ID: 25920758
    [No Abstract]   [Full Text] [Related]  

  • 14. Urologic Oncology.
    Burgess KE; DeRegis CJ
    Vet Clin North Am Small Anim Pract; 2019 Mar; 49(2):311-323. PubMed ID: 30635132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reason for euthanasia in dogs with urothelial carcinoma treated with chemotherapy or radiation therapy or both: A retrospective observational study.
    McKenna C; Poirier VJ; Oblak ML; Nykamp S; Mutsaers AJ
    J Vet Intern Med; 2024; 38(2):1127-1134. PubMed ID: 38317542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Review of Canine Cystectomy: Indications, Techniques, and Outcomes.
    Hildebrandt I; Culp WTN; Griffin MA
    Animals (Basel); 2023 Sep; 13(18):. PubMed ID: 37760296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of dogs with transitional cell carcinoma receiving medical therapy, with and without partial cystectomy.
    Bradbury ML; Mullin CM; Gillian SD; Weisse C; Bergman PJ; Morges MA; May LR; Vail DM; Clifford CA
    Can Vet J; 2021 Feb; 62(2):133-140. PubMed ID: 33542551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostatic Localization of a Migrating Grass Awn Foreign Body in a Dog.
    Marchesi MC; Moretti G; Angeli G; Birettoni F; Porciello F; Bufalari A; Caivano D
    Vet Sci; 2020 Nov; 7(4):. PubMed ID: 33260383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative evaluation of canine urinary bladder transitional cell carcinoma using contrast-enhanced ultrasonography.
    Macrì F; Di Pietro S; Mangano C; Pugliese M; Mazzullo G; Iannelli NM; Angileri V; Morabito S; De Majo M
    BMC Vet Res; 2018 Mar; 14(1):84. PubMed ID: 29530040
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.